Sunday, March 05, 2023 6:46:46 PM
Thanks Doc, you're right, I probably didn't figure where we'd have been if it hadn't been for the spoofing properly. A $5 share price being anticipated near term would certainly justify a far greater award, and probably a far bigger penalty if they wanted to send a message to the MM's.
Frankly I've seen many suits where the penalty awarded was a substantial multiple of the initial judgement. It will be interesting to watch all the legal moves that occur prior to this coming to trial if it doesn't settle. I suspect that the MM's profits will work in NWBO's favor when it comes to properly valuing the suit, and awarding a penalty that really sends them a message. I don't think we'll be looking at triple digit billions, but into double digits is very possible.
I don't know if the jury breaks down how much is owed by each MM, or just how it's broken down, but in the end all that matters to NWBO is what they see from the suit, that should be substantial. The judgement may be subject to time delaying appeals, but I believe such appeals can add to the award, so there's no telling if they'll pay immediately, or delay by appealing, and risk a greater loss.
Gary
Frankly I've seen many suits where the penalty awarded was a substantial multiple of the initial judgement. It will be interesting to watch all the legal moves that occur prior to this coming to trial if it doesn't settle. I suspect that the MM's profits will work in NWBO's favor when it comes to properly valuing the suit, and awarding a penalty that really sends them a message. I don't think we'll be looking at triple digit billions, but into double digits is very possible.
I don't know if the jury breaks down how much is owed by each MM, or just how it's broken down, but in the end all that matters to NWBO is what they see from the suit, that should be substantial. The judgement may be subject to time delaying appeals, but I believe such appeals can add to the award, so there's no telling if they'll pay immediately, or delay by appealing, and risk a greater loss.
Gary
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
